Johnson Health Tech .Co., Ltd. (TPE:1736)
Taiwan · Delayed Price · Currency is TWD 125.50
-3.50 (-2.71%)
Sep 18, 2026, 1:30 PM CST
Johnson Health Tech .Co. Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 39,138 | 45,813 | 55,959 | 20,811 | 21,030 | 17,036 | |
Market Cap Growth | -10.73% | -18.13% | 168.89% | -1.04% | 23.45% | -39.20% |
Enterprise Value | 52,760 | 62,735 | 71,844 | 35,580 | 37,548 | 30,982 |
Last Close Price | 129.00 | 145.75 | 173.51 | 64.06 | 64.31 | 51.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.68 | 16.66 | 23.03 | 29.32 | 49.02 | 446.57 |
Forward PE | 9.33 | 14.60 | 22.92 | 12.68 | 20.38 | 11.43 |
PS Ratio | 0.69 | 0.84 | 1.17 | 0.55 | 0.63 | 0.55 |
PB Ratio | 2.85 | 3.34 | 4.65 | 2.16 | 2.22 | 1.82 |
P/TBV Ratio | 3.56 | 4.17 | 6.08 | 3.05 | 3.18 | 3.00 |
P/FCF Ratio | 12.29 | 52.66 | 147.35 | 6.52 | - | - |
P/OCF Ratio | 8.12 | 17.78 | 53.11 | 5.42 | 53.59 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.93 | 1.16 | 1.50 | 0.94 | 1.12 | 1.01 |
EV/EBITDA Ratio | 8.57 | 14.85 | 18.65 | 19.64 | 116.16 | 48.60 |
EV/EBIT Ratio | 11.60 | 17.47 | 22.51 | 28.64 | - | 200.94 |
EV/FCF Ratio | 16.57 | 72.11 | 189.17 | 11.15 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.24 | 1.40 | 1.44 | 1.67 | 1.95 | 1.71 |
Debt / EBITDA Ratio | 2.76 | 3.70 | 3.70 | 6.19 | 19.08 | 13.68 |
Debt / FCF Ratio | 5.34 | 22.02 | 45.60 | 5.06 | - | - |
Net Debt / Equity Ratio | 0.99 | 1.15 | 1.21 | 1.43 | 1.57 | 1.43 |
Net Debt / EBITDA Ratio | 2.62 | 3.75 | 3.80 | 7.62 | 46.16 | 21.04 |
Net Debt / FCF Ratio | 4.28 | 18.20 | 38.49 | 4.32 | -973.71 | -3.17 |
Asset Turnover | 1.26 | 1.16 | 1.19 | 1.01 | 0.91 | 0.93 |
Inventory Turnover | 2.06 | 2.19 | 2.26 | 1.88 | 1.62 | 1.72 |
Quick Ratio | 0.64 | 0.78 | 0.78 | 0.73 | 0.51 | 0.50 |
Current Ratio | 1.26 | 1.37 | 1.46 | 1.30 | 1.07 | 1.11 |
Return on Equity (ROE) | 27.91% | 21.33% | 22.41% | 7.42% | 2.38% | 1.01% |
Return on Assets (ROA) | 6.35% | 4.79% | 4.98% | 2.06% | -0.36% | 0.29% |
Return on Invested Capital (ROIC) | 11.44% | 8.94% | 8.87% | 2.76% | -0.68% | 0.46% |
Return on Capital Employed (ROCE) | 20.50% | 14.40% | 14.00% | 6.80% | -1.50% | 1.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.57% | 6.00% | 4.34% | 3.41% | 2.04% | 0.22% |
FCF Yield | 8.14% | 1.90% | 0.68% | 15.34% | -0.07% | -24.82% |
Dividend Yield | 3.59% | 3.09% | 2.31% | 1.56% | 0.93% | 0.97% |
Payout Ratio | 36.18% | 44.14% | 12.46% | 25.61% | 35.27% | 888.38% |
Buyback Yield / Dilution | -0.04% | -0.11% | -0.11% | -0.10% | -0.01% | 0.02% |
Total Shareholder Return | 3.45% | 2.97% | 2.19% | 1.46% | 0.92% | 0.99% |